Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc

被引：0
|
作者：
Haitao Luo
Matthew K Daddysman
Gary O Rankin
Bing-Hua Jiang
Yi C Chen
机构：
[1] Alderson-Broaddus College,Natural Science Division
[2] West Virginia University,Mary Babb Randolph Cancer Center, Department of Microbiology, Immunology, and Cell Biology
[3] Joan C. Edwards School of Medicine,Department of Pharmacology, Physiology and Toxicology
[4] Marshall University,undefined
来源：
Cancer Cell International | / 10卷
关键词：
Ovarian Cancer; Ovarian Cancer Cell; CDKN1A Gene; Tocopherol Succinate; Ovarian Cancer Cell Growth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation
    Kobayashi, Noriko
    Abedini, Mohammadreza
    Sakuragi, Noriaki
    Tsang, Benjamin K.
    JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [32] PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation
    Noriko Kobayashi
    Mohammadreza Abedini
    Noriaki Sakuragi
    Benjamin K Tsang
    Journal of Ovarian Research, 6
  • [33] Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells
    Wang, Haixia
    Zhang, Zhifeng
    Wei, Xiuping
    Dai, Ruizhen
    JOURNAL OF OVARIAN RESEARCH, 2015, 8
  • [34] Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells
    Haixia Wang
    Zhifeng Zhang
    Xiuping Wei
    Ruizhen Dai
    Journal of Ovarian Research, 8
  • [35] Theaflavin-3,3-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells
    Pan, Haibo
    Kim, Eunhye
    Rankin, Gary O.
    Rojanasakul, Yon
    Tu, Youying
    Chen, Yi Charlie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [36] Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells
    Jiao, Jin-Wen
    Wen, Fang
    ONCOLOGY REPORTS, 2011, 25 (03) : 781 - 788
  • [37] Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3
    Fu, Siqing
    Li, Yanfang
    Huang, Jie
    Liu, Tao
    Hong, Zhen
    Chen, Aiping
    Bast, Robert C.
    Kavanagh, John J.
    Gershenson, David M.
    Sood, Anil K.
    Hu, Wei
    CANCER BIOLOGY & THERAPY, 2012, 13 (11) : 1034 - 1041
  • [38] Dietary flavonoid tectochrysin synergistically enhances cisplatin sensitivity on ovarian cancer cells through targeting the CDK1/cyclin B1 pathway
    Liu, Shasha
    Guo, Yuling
    Jiang, Feiya
    Liu, Caiyan
    Zhang, Wenwen
    Zhao, Hui
    Qu, Pengpeng
    JOURNAL OF FUNCTIONAL FOODS, 2024, 117
  • [39] Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1alpha in human ovarian cancer cells
    Ohta, Tsuyoshi
    Takahashi, Toshifumi
    Shibuya, Tae
    Amita, Mitsuyoshi
    Henmi, Noriko
    Takahashi, Kazuhiro
    Kurachi, Hirohisa
    CANCER BIOLOGY & THERAPY, 2012, 13 (01) : 25 - 33
  • [40] hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells
    Lei Li
    Den-bang Chen
    Chao Lin
    Kang Cao
    Yang Wan
    Xin-yu Zhao
    Chun-lai Nie
    Zhu Yuan
    Yu-quan Wei
    Apoptosis, 2013, 18 : 467 - 479
12345